Anti-tissue plasminogen activator (tPA) as an effective therapy of neonatal hypoxia-ischemia with and without inflammation. [PDF]
CNS Neurosci Ther, 2015 Yang D, Kuan CY.
europepmc +1 more source
Plasminogen activator inhibitor-1 regulates the vascular expression of vitronectin. [PDF]
J Thromb Haemost, 2017 Luo M, Ji Y, Luo Y, Li R, Fay WP, Wu J.
europepmc +1 more source
Development of Activity-Based Proteomic Probes for Protein Citrullination. [PDF]
Curr Top Microbiol Immunol, 2019 Nemmara VV, Thompson PR.
europepmc +1 more source
Inhibition of plasminogen activator inhibitor-1 is a potential therapeutic strategy in ovarian cancer. [PDF]
Cancer Biol Ther, 2015 Mashiko S +10 more
europepmc +1 more source
Inhibition of Mycobacterium tuberculosis-induced signalling by transforming growth factor-β in human mononuclear phagocytes. [PDF]
Scand J Immunol, 2012 Wu M, Aung H, Hirsch CS, Toossi Z.
europepmc +1 more source
Conformationally rigid histone deacetylase inhibitors correct DF508-CFTR protein function [PDF]
, 2011 Balch, William E. +7 more
core
Increased thrombin-activatable fibrinolysis inhibitor and decreased tissue factor pathway inhibitor and thrombomodulin levels in children with hypothyroidism. [PDF]
J Clin Res Pediatr Endocrinol, 2012 Alioğlu B +3 more
europepmc +1 more source
Synthesis and structure-activity relationship of liposomal substrates for phospholipase A(2) [PDF]
, 2011 Clausen, Mads Hartvig +1 more
core
Multiple radiations and its effect on biological system - a review on <i>in vitro</i> and <i>in vivo</i> mechanisms. [PDF]
Ann MedBalasubramanian D +3 more
europepmc +1 more source
Characterization of a novel class of polyphenolic inhibitors of plasminogen activator inhibitor-1. [PDF]
J Biol Chem, 2010 Cale JM +8 more
europepmc +1 more source